Oct 28 (Reuters) - Neovasc Inc NVCN.TO :
* NEOVASC ANNOUNCES FDA ADVISORY PANEL RESULT ON NEOVASC REDUCER™ MEDICAL DEVICE FOR THE TREATMENT OF REFRACTORY ANGINA
* NEOVASC INC - FDA'S CIRCULATORY SYSTEM DEVICES ADVISORY PANEL VOTED 14 TO 4 "IN FAVOR" THAT NEOVASC REDUCER IS SAFE WHEN USED AS INTENDED
* NEOVASC - FDA'S CIRCULATORY SYSTEM DEVICES ADVISORY PANEL VOTED 1 TO 17 "AGAINST" ISSUE OF A REASONABLE ASSURANCE OF EFFECTIVENESS ON NEOVASC REDUCER
* NEOVASC - FDA ADVISORY PANEL VOTED 13 TO 3 "AGAINST" (2 ABSTAINED) ON WHETHER RELATIVE BENEFITS OUTWEIGHED RELATIVE RISKS ON NEOVASC REDUCER